Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
Today's episode features Dr. Sean Gregory, Vice President, Health Economics and Market Access for Cognito Therapeutics a company developing a novel device-based approach to treating Alzheimer’s disease. We discuss the innovative nature of their device, the results to date and emerging signals in neuroscience research for a range of neurodegenerative disorders including parkinson's disease and MS.
Join us!
==##==
